Lv4
580 积分 2023-10-09 加入
Efficacy and safety of Privigen®, a novel liquid intravenous immunoglobulin formulation, in adolescent and adult patients with chronic immune thrombocytopenic purpura
1天前
待确认
Safety and efficacy of intravenous immunoglobulin (Flebogamma® 10% DIF) in patients with immune thrombocytopenic purpura
1天前
待确认
Safety and efficacy of intravenous immunoglobulin (Flebogamma® 10% DIF) in patients with immune thrombocytopenic purpura
1天前
已关闭
Safety and efficacy of intravenous immunoglobulin (Flebogamma® 10% DIF) in patients with immune thrombocytopenic purpura
1天前
已关闭
D-dimer: Preanalytical, analytical, postanalytical variables, and clinical applications
8天前
已完结
Efficacy and safety of Hizentra® in patients with primary immunodeficiency after a dose-equivalent switch from intravenous or subcutaneous replacement therapy
12天前
已完结
“Off-the-Shelf” Allogeneic CAR Cell Therapy—Neglected HvG Effect
17天前
已完结
The origin and fate of γδT cell subsets
17天前
已完结
From backstage to the spotlight: γδT cells in cancer
17天前
已完结
From backstage to the spotlight: γδT cells in cancer
17天前
已完结
皖公网安备34019202002308
